# Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis

> **NCT02952079** · NA · COMPLETED · sponsor: **University of the Incarnate Word** · enrollment: 11 (actual)

## Conditions studied

- Meibomian Gland Dysfunction
- Dry Eye
- Posterior Blepharitis

## Interventions

- **DEVICE:** Blephex
- **DEVICE:** MiboFlo

## Key facts

- **NCT ID:** NCT02952079
- **Lead sponsor:** University of the Incarnate Word
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02952079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02952079, "Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02952079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*